These TSX stocks are down over 34% year-to-date, reflecting tariff-related uncertainties and the volatility in crude oil ...

The last 12 months have seen a meaningful step up in performance. In the second quarter of 2025, comparable earnings before interest, taxes, depreciation, and amortization (EBITDA) hit $2.6 billion, ...

In a market-cap-weighted index, winners naturally take up more space over time, while underperformers like BCE fade into the ...

Investing in top Canadian stocks such as Profound Medical offers you with an opportunity to benefit from outsized gains in ...